User menu

Tumour antigens recognized by T lymphocytes

Bibliographic reference Van den Eynde, Benoît ; Pang, Ken C. ; Chen, Weisan. Tumour antigens recognized by T lymphocytes. In: Encyclopedia of Life Sciences, John Wiley & Sons, Ltd  2007
Permanent URL http://hdl.handle.net/2078.1/131775
  1. Boon Thierry, Cerottini Jean-Charles, Van den Eynde Benoit, van der Bruggen Pierre, Van Pel Aline, Tumor Antigens Recognized by T Lymphocytes, 10.1146/annurev.iy.12.040194.002005
  2. Boon T., Human tumor antigens recognized by T lymphocytes, 10.1084/jem.183.3.725
  3. Bronte Vincenzo, Zanovello Paola, Regulation of immune responses by L-arginine metabolism, 10.1038/nri1668
  4. Davis I. D., Chen W., Jackson H., Parente P., Shackleton M., Hopkins W., Chen Q., Dimopoulos N., Luke T., Murphy R., Scott A. M., Maraskovsky E., McArthur G., MacGregor D., Sturrock S., Tai T. Y., Green S., Cuthbertson A., Maher D., Miloradovic L., Mitchell S. V., Ritter G., Jungbluth A. A., Chen Y.-T., Gnjatic S., Hoffman E. W., Old L. J., Cebon J. S., Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans, 10.1073/pnas.0403572101
  5. De Plaen Etienne, Lurquin Christophe, Lethé Bernard, van der Bruggen Pierre, Brichard Vincent, Renauld Jean-Christophe, Coulie Pierre, Van Pel Aline, Boon Thierry, Identification of Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes, 10.1006/meth.1997.0462
  6. Dudley M. E., Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes, 10.1126/science.1076514
  7. Figdor Carl G, de Vries I Jolanda M, Lesterhuis W Joost, Melief Cornelis J M, Dendritic cell immunotherapy: mapping the way, 10.1038/nm1039
  8. Frazer Ian H., Prevention of cervical cancer through papillomavirus vaccination, 10.1038/nri1260
  9. Old Lloyd J., Chen Yao-Tseng, New Paths in Human Cancer Serology, 10.1084/jem.187.8.1163
  10. Pashine Achal, Valiante Nicholas M, Ulmer Jeffrey B, Targeting the innate immune response with improved vaccine adjuvants, 10.1038/nm1210
  11. Peggs Karl S, Quezada Sergio A, Korman Alan J, Allison James P, Principles and use of anti-CTLA4 antibody in human cancer immunotherapy, 10.1016/j.coi.2006.01.011
  12. Rosenberg Steven A, Yang James C, Restifo Nicholas P, Cancer immunotherapy: moving beyond current vaccines, 10.1038/nm1100
  13. Simpson Andrew J. G., Caballero Otavia L., Jungbluth Achim, Chen Yao-Tseng, Old Lloyd J., Cancer/testis antigens, gametogenesis and cancer, 10.1038/nrc1669
  14. Spiotto Michael T, Rowley Donald A, Schreiber Hans, Bystander elimination of antigen loss variants in established tumors, 10.1038/nm999
  15. Uyttenhove Catherine, Pilotte Luc, Théate Ivan, Stroobant Vincent, Colau Didier, Parmentier Nicolas, Boon Thierry, Van den Eynde Benoît J, Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase, 10.1038/nm934
  16. Van den Eynde Benoît J, van der Bruggen Pierre, T cell defined tumor antigens, 10.1016/s0952-7915(97)80050-7
  17. Villa Luisa L, Costa Ronaldo LR, Petta Carlos A, Andrade Rosires P, Ault Kevin A, Giuliano Anna R, Wheeler Cosette M, Koutsky Laura A, Malm Christian, Lehtinen Matti, Skjeldestad Finn Egil, Olsson Sven-Eric, Steinwall Margareta, Brown Darron R, Kurman Robert J, Ronnett Brigitte M, Stoler Mark H, Ferenczy Alex, Harper Diane M, Tamms Gretchen M, Yu Jimmy, Lupinacci Lisa, Railkar Radha, Taddeo Frank J, Jansen Kathrin U, Esser Mark T, Sings Heather L, Saah Alfred J, Barr Eliav, Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial, 10.1016/s1470-2045(05)70101-7
  18. Vonderheide R. H., Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T Lymphocytes, 10.1158/1078-0432.ccr-0620-3
  19. Yu Ping, Rowley Donald A, Fu Yang-Xin, Schreiber Hans, The role of stroma in immune recognition and destruction of well-established solid tumors, 10.1016/j.coi.2006.01.004
  20. Zou Weiping, Regulatory T cells, tumour immunity and immunotherapy, 10.1038/nri1806
  21. Boon Thierry, Coulie Pierre G., Eynde Benoît J. Van den, Bruggen Pierre van der, HUMAN T CELL RESPONSES AGAINST MELANOMA, 10.1146/annurev.immunol.24.021605.090733
  22. Gilboa Eli, Opinion: The promise of cancer vaccines, 10.1038/nrc1359
  23. Houghton Alan N, Gold Jason S, Blachere Nathalie E, Immunity against cancer: lessons learned from melanoma, 10.1016/s0952-7915(00)00195-3
  24. Rammensee Hans-Georg, Weinschenk Toni, Gouttefangeas Cecile, Stevanovi Eq Stefan, Towards patient-specific tumor antigen selection for vaccination, 10.1034/j.1600-065x.2002.18815.x
  25. van der Bruggen Pierre, Zhang Yi, Chaux Pascal, Stroobant Vincent, Panichelli Christophe, Schultz Erwin S., Chapiro Jacques, Van den Eynde Benoit J., Brasseur Francis, Boon Thierry, Tumor-specific shared antigenic peptides recognized by human T cells, 10.1034/j.1600-065x.2002.18806.x
  26. Zou Weiping, Immunosuppressive networks in the tumour environment and their therapeutic relevance, 10.1038/nrc1586
  27. van der Bruggen P Stroobart V Van Pel A. Van den Eynde B 2006 http://cancerimmunity.org/peptidedatabase/Tcellepitopes.htm